K131892 is an FDA 510(k) clearance for the EV1000 CLINICAL PLATFORM. This device is classified as a Computer, Diagnostic, Pre-programmed, Single-function (Class II - Special Controls, product code DXG).
Submitted by Edwards Lifesciences, LLC (Irvine, US). The FDA issued a Cleared decision on May 22, 2014, 331 days after receiving the submission on June 25, 2013.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1435.
| 510(k) Number | K131892 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 25, 2013 |
| Decision Date | May 22, 2014 |
| Days to Decision | 331 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXG — Computer, Diagnostic, Pre-programmed, Single-function |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1435 |